Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Preemptive Intervention in Airflow Obstruction Status Prevents the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Stem Cell Transplantation: Multicenter, Prospective Phase II Study (Chiba AFO-01)

Blood (2023) 142 (Supplement 1): 2204.

https://doi.org/10.1182/blood-2023-178437

Published: 2023

Journal Articles

Regulation of Metabolic Homeostasis By TRAF6 Contributes to the Leukemia Progression

Shinichiro Matsui, Chihiro Ri, Lyndsey C. Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Koutaro Yokote, Daniel T. Starczynowski, Emiko Sakaida, Tomoya Muto

Blood (2023) 142 (Supplement 1): 1370.

https://doi.org/10.1182/blood-2023-178962

Published: 2023

Journal Articles

Exhausted T Cells Characterized By Upregulation of Specific Transcription Factors Are Increased in a Mouse Model of De Novo Mature B Cell Neoplasms

Blood (2022) 140 (Supplement 1): 4240–4241.

https://doi.org/10.1182/blood-2022-158111

Published: 2022

Journal Articles

Detection of Clonal Plasma Cells in POEMS Syndrome Using Multiparameter Flow Cytometry

Blood (2021) 138 (Supplement 1): 2697.

https://doi.org/10.1182/blood-2021-150900

Published: 2021

Journal Articles

Genomic Analysis of Diffuse Large B Cell Lymphoma in a Japanese Cohort Using Targeted DNA Sequencing

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-134891

Published: 2020

Journal Articles

Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity

Tomoya Muto, MD PhD, Maria Guillamot, PhD, Jing Fang, MD PhD, Luna Zea Redondo, MS, Kwangmin Choi, PhD, Yixiao Gong, MSc, Callum S Walker, MSc, Kathleen Hueneman, Lyndsey C Bolanos, BSc, Laura Barreyro, PhD, Lynn Lee, MD, Kenneth D Greis, PhD, Alireza Khodadadi-Jamayran, M.Sc., Amaia Lujambio, PhD, Scott W. Lowe, PhD, Iannis Aifantis, PhD, Daniel T. Starczynowski, PhD

Blood (2019) 134 (Supplement_1): 727.

https://doi.org/10.1182/blood-2019-121423

Published: 2019

Journal Articles

Therapeutic Targeting of the Ubiquitin Conjugating Enzyme UBE2N in Myeloid Malignancies

Blood (2018) 132 (Supplement 1): 4050.

https://doi.org/10.1182/blood-2018-99-115359

Published: 2018

Journal Articles

Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome

Chikako Ohwada, Emiko Sakaida, Chika Kawajiri-Manako, Yuhei Nagao, Nagisa Oshima-Hasegawa, Emi Togasaki, Tomoya Muto, Shokichi Tsukamoto, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Masahiro Takeuchi, Naomi Shimizu, Sonoko Misawa, Tohru Iseki, Satoshi Kuwabara, Chiaki Nakaseko

Blood (2018) 131 (19): 2173–2176.

https://doi.org/10.1182/blood-2017-07-795385

Published: 2018

Includes: Supplemental data

Journal Articles

Innate Immune Signal Pathway Activation Induced By Combined Loss of Del(5q) MDS Genes, Tifab and Mir-146a, Accelerates Hematopoietic Stem Cell Exhaustion Driven By Chronic Exposure to a TLR Ligands

Tomoya Muto, MD PhD, Melinda Varney, PhD, Callum Walker, MSc, Lyndsey Bolanos, BSc, Kathleen Hueneman, BSc, Daniel Starczynowski, PhD

Blood (2017) 130 (Supplement 1): 1674.

https://doi.org/10.1182/blood.V130.Suppl_1.1674.1674

Published: 2017

Journal Articles

Diverse Role of DNA Hypermethylation in Reduced Expression of Tumor Suppressor NR4A3 in Acute Myeloid Leukemia

Ryo Shimizu, MD, Tomoya Muto, MD PhD, Masahiro Takeuchi, MD PhD, Shuhei Koide, Yuhei Nagao, MD, Chika Kawajiri, MD, Emi Togasaki, MD, Nagisa Hasegawa, MD, Shio Sakai, MD, PhD, Yusuke Takeda, MD PhD, Naoya Mimura, MD PhD, Chikako Ohwada, MD PhD, Emiko Sakaida, MD PhD, Tohru Iseki, MD PhD, Koutaro Yokote, MD PhD, Atsushi Iwama, MD PhD, Chiaki Nakaseko, MD PhD

Blood (2015) 126 (23): 3640.

https://doi.org/10.1182/blood.V126.23.3640.3640

Published: 2015

Journal Articles

Combinatorial Epigenetic Aberration Propagates in Myelodysplastic Syndrome in the Setting of Concurrent Loss of Tet2 and Ezh2

Nagisa Hasegawa, MD, Goro Sashida, MD PhD, Motohiko Oshima, PhD, Hirotaka Matsui, MD PhD, Atsunori Saraya, Changshan Wang, PhD, Tomoya Muto, MD PhD, Chiaki Nakaseko, MD PhD, Koutaro Yokote, MD PhD, Atsushi Iwama, MD PhD

Blood (2015) 126 (23): 712.

https://doi.org/10.1182/blood.V126.23.712.712

Published: 2015

Journal Articles

Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner

Makiko Mochizuki-Kashio, Kazumasa Aoyama, Goro Sashida, Motohiko Oshima, Takahisa Tomioka, Tomoya Muto, Changshan Wang, Atsushi Iwama

Blood (2015) 126 (10): 1172–1183.

https://doi.org/10.1182/blood-2015-03-634428

Published: 2015

Includes: Supplemental data

Journal Articles

The Biological Function of DNA Hypermethylation in Murine MDS Model Lacking Tet2 and Ezh2

Nagisa Hasegawa, MD, Goro Sashida, MD PhD, Motohiko Oshima, PhD, Hirotaka Matsui, MD PhD, Changshan Wang, PhD, Tomoya Muto, MD PhD, Chiaki Nakaseko, MD PhD, Kotaro Yokote, MD PhD, Atsushi Iwama, MD PhD

Blood (2014) 124 (21): 4596.

https://doi.org/10.1182/blood.V124.21.4596.4596

Published: 2014

Journal Articles

Soluble LR11, GCSF−induced Migration Regulator from Myeloid Cells, Is Highly Increased in Chronic Myeloid Leukemia

Naomi Shimizu, MD PhD, Hideaki Bujo, MD PhD, Meizi Jiang, MD PhD, Keigo Nishii, Emiko Sakaida, MD PhD, Chikako Ohwada, MD PhD, Masahiro Takeuchi, MD PhD, Naoya Mimura, MD PhD, Yusuke Takeda, MD PhD, Shokichi Tsukamoto, MD PhD, Tomoya Muto, MD PhD, Ichiro Tatsuno, MD PhD, Chiaki Nakaseko, MD PhD

Blood (2014) 124 (21): 4961.

https://doi.org/10.1182/blood.V124.21.4961.4961

Published: 2014

Journal Articles

Impact of Serum Soluble LR11 on Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Multicenter Prospective Study

Blood (2014) 124 (21): 1661.

https://doi.org/10.1182/blood.V124.21.1661.1661

Published: 2014

Journal Articles

Activation of Rac1 through FARP1 Induces Dexamethasone Resistance in Multiple Myeloma Cells

Atsuko Yamazaki, MD, Masahiro Takeuchi, MD PhD, Tatsuzo Mishina, MD, Miki Yamazaki, MD, Chika Kawajiri, MD, Ryoh Simizu, MD, Emi Togasaki, MD, Yasumasa Sugita, MD, Tomoya Muto, MD PhD, Shio Sakai, MD PhD, Yusuke Takeda, MD PhD, Naoya Mimura, MD PhD, Chikako Ohwada, MD PhD, Emiko Sakaida, MD, PhD, Tohru Iseki, MD PhD, Chiaki Nakaseko, MD PhD

Blood (2014) 124 (21): 2248.

https://doi.org/10.1182/blood.V124.21.2248.2248

Published: 2014

Journal Articles

Partial Splenic Embolization For The Treatment Of Steroid-Resistant Chronic Idiopathic Thrombocytopenic Purpura

Chiaki Nakaseko, MD, PhD, Emi Togasaki, MD, Naomi Shimizu, MD, PhD, Emiko Sakaida, MD, PhD, Masahiro Takeuchi, MD, PhD, Chikako Ohwada, MD, PhD, Yusuke Takeda, MD, PhD, Shio Sakai, MD, PhD, Shokichi Tsukamoto, MD, Takeharu Kawaguchi, MD, PhD, Tomoya Muto, MD, PhD, Tohru Iseki, MD, PhD, Koutaro Yokote, MD, PhD

Blood (2013) 122 (21): 3543.

https://doi.org/10.1182/blood.V122.21.3543.3543

Published: 2013

Journal Articles

Tetraspanin CD9 Inhibits ADAM17-Mediated LR11 Shedding In Leukemia Cells

Shokichi Tsukamoto, MD, Masahiro Takeuchi, MD, PhD, Takeharu Kawaguchi, MD, PhD, Emi Togasaki, MD, Atsuko Yamazaki, MD, Yasumasa Sugita, MD, Tomoya Muto, MD, PhD, Shio Sakai, MD, PhD, Yusuke Takeda, MD, PhD, Chikako Ohwada, MD, PhD, Naomi Shimizu, MD, PhD, Emiko Sakaida, MD, PhD, Keigo Nishii, Meizi Jiang, MD, PhD, Tohru Iseki, MD, PhD, Koutaro Yokote, MD, PhD, Hideaki Bujo, MD, PhD, Chiaki Nakaseko, M.D., Ph.D.

Blood (2013) 122 (21): 1035.

https://doi.org/10.1182/blood.V122.21.1035.1035

Published: 2013

Journal Articles

Concurrent Loss Of Ezh2 and Tet2 Cooperates In The Pathogenesis Of Myelodysplastic Disorders,

Tomoya Muto, MD, PhD, Goro Sashida, MD, PhD, Motohiko Oshima, PhD, George R Wendt, Makiko Mochizuki-Kashio, PhD, Masashi Sanada, MD, Satoru Miyagi, PhD., Atsunori Saraya, MS, Chiaki Nakaseko, M.D., Ph.D., Koutaro Yokote, MD, PhD, Kazuya Shimoda, MD, PhD, Haruhiko Koseki, MD, PhD, Yutaka Suzuki, PhD, Sumio Sugano, PhD, Seishi Ogawa, MD, PhD, Atsushi Iwama, MD, PhD

Blood (2013) 122 (21): 480.

https://doi.org/10.1182/blood.V122.21.480.480

Published: 2013

Journal Articles

Loss of Ezh2 Promotes the Development of Mutant-RUNX1 Induced MDS

Goro Sashida, MD, PhD, Satomi Tanaka, MD, Makiko Mochizuki-Kashio, PhD, Atsunori Saraya, MS, Tomoya Muto, MD, Atsushi Iwama, MD, PhD

Blood (2012) 120 (21): 402.

https://doi.org/10.1182/blood.V120.21.402.402

Published: 2012

NARROW

Preemptive Intervention in Airflow Obstruction Status Prevents the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Stem Cell Transplantation: Multicenter, Prospective Phase II Study (Chiba AFO-01)

Regulation of Metabolic Homeostasis By TRAF6 Contributes to the Leukemia Progression

Exhausted T Cells Characterized By Upregulation of Specific Transcription Factors Are Increased in a Mouse Model of De Novo Mature B Cell Neoplasms

Detection of Clonal Plasma Cells in POEMS Syndrome Using Multiparameter Flow Cytometry

Genomic Analysis of Diffuse Large B Cell Lymphoma in a Japanese Cohort Using Targeted DNA Sequencing

Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity

Therapeutic Targeting of the Ubiquitin Conjugating Enzyme UBE2N in Myeloid Malignancies

Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome

Innate Immune Signal Pathway Activation Induced By Combined Loss of Del(5q) MDS Genes, Tifab and Mir-146a, Accelerates Hematopoietic Stem Cell Exhaustion Driven By Chronic Exposure to a TLR Ligands

Diverse Role of DNA Hypermethylation in Reduced Expression of Tumor Suppressor NR4A3 in Acute Myeloid Leukemia

Combinatorial Epigenetic Aberration Propagates in Myelodysplastic Syndrome in the Setting of Concurrent Loss of Tet2 and Ezh2

Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner

The Biological Function of DNA Hypermethylation in Murine MDS Model Lacking Tet2 and Ezh2

Soluble LR11, GCSF−induced Migration Regulator from Myeloid Cells, Is Highly Increased in Chronic Myeloid Leukemia

Impact of Serum Soluble LR11 on Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Multicenter Prospective Study

Activation of Rac1 through FARP1 Induces Dexamethasone Resistance in Multiple Myeloma Cells

Partial Splenic Embolization For The Treatment Of Steroid-Resistant Chronic Idiopathic Thrombocytopenic Purpura

Tetraspanin CD9 Inhibits ADAM17-Mediated LR11 Shedding In Leukemia Cells

Concurrent Loss Of Ezh2 and Tet2 Cooperates In The Pathogenesis Of Myelodysplastic Disorders,

Loss of Ezh2 Promotes the Development of Mutant-RUNX1 Induced MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only